IonOpticks and Newomics broaden chromatography accessibility for Agilent mass specs, with Shimadzu pending
- S&P 500, Dow close slightly up; Nvidia gains after the bell
- Nvidia guidance tops estimates as AI-led chip demand continues; shares jump
- More signs inflation is slowing before pivot to cuts as upside risks emerge: Fed
- Rivian production guidance falls short; shares slump
- Yields rise on Fed fears of cutting rates too soon, stocks mixed
IonOpticks is renowned for its class-leading chromatography solutions, particularly the Aurora Series, which are celebrated for their precision, efficiency, and reliability in protein separation and analysis. This partnership underscores IonOpticks' commitment to broadening the accessibility and application of its top-tier chromatography technologies.
Thanks to Newomics' innovative development of the UniESI source, IonOpticks'
The Aurora Series column range has a proven track record of maximizing the performance of leading mass spec instruments by brands including Thermo, SCIEX and Bruker. This collaboration marks a significant advancement in IonOpticks' drive to empower all researchers with the best chromatography, regardless of the mass spec they are using, with a similar solution for Shimadzu mass specs coming soon.
"We are setting new standards in sensitivity and efficiency, enabling scientists to delve deeper into the complexities of biological systems and make groundbreaking discoveries. We believe this is a pivotal step towards realizing the full potential of mass spectrometry in both research and clinical applications,"
Access to the IonOpticks Aurora Series columns with the Newomics UniESI source unlocks exciting opportunities for Agilent MS users to exploit the increased sensitivity, depth and reproducibility that these columns provide, and enables them to realize the full potential of their mass spectrometers.
Researchers and scientists can learn more about IonOpticks columns for Agilent mass spectrometers by emailing [email protected]
IonOpticks produces high-performance nanoflow chromatography solutions for the global research community. They specialize in the development and manufacture of columns for analytical applications in liquid chromatography with mass spectrometry (LC-MS) and high-end proteomics. Their highly reproducible methods provide a unique ability to enhance the sensitivity of mass spectrometry sample analysis, enabling scientists and clinicians to discover more from their samples. The IonOpticks team are experts in a broad array of LC-MS platform technologies and are driven by the need to improve chromatographic performance in order to achieve data quality and deep proteome coverage on a whole new scale. IonOpticks columns are used for a broad range of applications within the field of biological and medical research including drug discovery, phosphoproteomics and shotgun proteomics. When powered by IonOpticks, the possibilities are endless.
Newomics Inc. is committed to pioneering platforms and solutions for precision medicine. Their M3 emitter product line and multi-nozzle emitter array (MEA) technology, which garnered the prestigious 2012 R&D 100 award, exemplify their dedication to innovation. Newomics' impact in the field is substantial, as evidenced by their ranking among the top 100 corporations for research in the natural sciences in
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synechron Earns a Great Place To Work® Certification In 12 Countries Globally
- Tax Systems Launches Alphamap, a Generative AI Powered Solution That Reduces Time for Trial Balance Mapping and Upload by 80%
- FRO – Invitation to Q4 2023 Results Conference Call and Webcast
Create E-mail Alert Related CategoriesPRNewswire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!